- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/113 - 1,3,4-OxadiazolesHydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 271/113
Total number of patents in this class: 280
10-year publication summary
|
16
|
26
|
26
|
30
|
22
|
18
|
17
|
18
|
30
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 2057 |
27 |
| King Faisal University | 908 |
16 |
| Bayer AG | 3308 |
10 |
| BASF SE | 20803 |
9 |
| Syngenta Crop Protection AG | 6036 |
7 |
| Cytokinetics, Inc. | 272 |
7 |
| Abbvie Inc. | 1803 |
6 |
| Calico Life Sciences LLC | 96 |
6 |
| Bayer Intellectual Property GmbH | 2519 |
5 |
| Oryzon Genomics S.A. | 106 |
5 |
| Novartis AG | 10883 |
4 |
| The General Hospital Corporation | 4710 |
4 |
| Northwestern University | 3366 |
4 |
| Denali Therapeutics Inc. | 240 |
4 |
| Microbiotix, Inc. | 41 |
4 |
| The Penn State Research Foundation | 1507 |
4 |
| Romark Laboratories L.C. | 52 |
4 |
| Qingdao Kingagroot Chemical Compound Co., Ltd. | 160 |
4 |
| Glaxo Group Limited | 4131 |
3 |
| AstraZeneca AB | 2933 |
3 |
| Other owners | 144 |